Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The best phone carrier delivers reliable service at an affordable cost while responding ...

Jose Armando Resendiz this weekend. The 2013-14 NBA Rookie of the Year was successful in his amateur boxing debut, battering Sam Khativ in a three-round heavyweight contest at Broad Street Brawl ...

Look back at all the key updates and watch the best video from the Spanish Grand Prix weekend at the Circuit de Barcelona-Catalunya.

To make matters worse, the owner’s insurance premium could increase by $1K annually for five years if an at-fault claim is filed Limited to just 349 examples, the Blower Jnr combines nostalgia ...